Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.35 |
| ▸ | BID | P55957 | 3/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.35 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.35 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3423038 | 0.86 | CYP3A4 (0.44) | CYP3A4CYP2D6CYP2C9LIPG | |
| SCHEMBL27540250 | 0.83 | CYP3A4 (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL24389142 | 0.83 | CYP3A4 (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL29619878 | 0.82 | CYP3A4 (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL21765629 | 0.82 | CYP3A4 (0.68) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| Ammonia Solution, Strong SCHEMBL8748451 | 0.82 | CYP3A4 (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL3820757 | 0.82 | CYP3A4 (0.54) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL29520482 | 0.81 | LIPG (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL245188 | 0.81 | LIPG (0.56) | CYP3A4CYP2D6CYP2C9LIPGTLR8 | |
| SCHEMBL25165512 | 0.80 | CYP3A4 (0.57) | CYP3A4CYP2D6CYP2C9LIPGTLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070235725-A1 | Ethynylene acene polymers and electronic devices generated therefrom | XEROX CORPORATION | 2007-10-11 | — | — | US | claimed |
| US-8129467-B2 | Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device | HITACHI CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8013052-B2 | Curable resin, production method thereof, epoxy resin composition, and electronic device | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-7795373-B2 | Ethynylene acene polymers | XEROX CORPORATION (US) | 2010-09-14 | — | — | US | disclosed |
| US-7586120-B2 | Ethynylene acene polymers and electronic devices generated therefrom | XEROX CORPORATION (US) | 2009-09-08 | — | — | US | disclosed |
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | HITACHI CHEMICAL CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090023855-A1 | NOVEL CURABLE RESIN, PRODUCTION METHOD THEREOF, EPOXY RESIN COMPOSITION, AND ELECTRONIC DEVICE | RESONAC CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20070238855-A1 | Ethynylene acene polymers | XEROX CORPORATION (US) | 2007-10-11 | — | — | US | disclosed |
| US-20070235725-A1 | Ethynylene acene polymers and electronic devices generated therefrom | XEROX CORPORATION | 2007-10-11 | — | — | US | disclosed |
| EP-0183191-B1 | THIENYLTHIAZOLE COMPOUNDS | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1989-05-10 | — | — | EP | disclosed |
| US-4720493-A | Thienylthiazole compounds | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1988-01-19 | — | — | US | disclosed |
| EP-0183191-A1 | Thienylthiazole compounds | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1986-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | NCAPH, RAD51, H1-2 | CYP3A4 3968/4885CYP2D6 4504/4885CYP2C9 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.